Ingevity Corp Files Proxy Materials

TL;DR

Ingevity filed proxy docs, likely for shareholder votes on exec pay/board.

AI Summary

Ingevity Corporation filed a Definitive Additional Materials proxy statement on March 20, 2025. This filing is related to their annual meeting and likely concerns executive compensation, board nominations, or other shareholder proposals. The company is incorporated in Delaware and headquartered in North Charleston, SC.

Why It Matters

Proxy statements provide shareholders with crucial information to make informed voting decisions on company matters, including executive pay and board composition.

Risk Assessment

Risk Level: low — This filing is a routine proxy statement, indicating standard corporate governance procedures rather than an immediate financial event.

Key Players & Entities

• Ingevity Corporation (company) — Registrant
• 0001140361-25-009731 (filing_id) — Accession Number
• 20250320 (date) — Filing Date
• North Charleston, SC (location) — Company Headquarters

FAQ

From the Filing

0001140361-25-009731.txt : 20250320 0001140361-25-009731.hdr.sgml : 20250320 20250320173015 ACCESSION NUMBER: 0001140361-25-009731 CONFORMED SUBMISSION TYPE: DEFA14A PUBLIC DOCUMENT COUNT: 39 FILED AS OF DATE: 20250320 DATE AS OF CHANGE: 20250320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ingevity Corp CENTRAL INDEX KEY: 0001653477 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474027764 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: DEFA14A SEC ACT: 1934 Act SEC FILE NUMBER: 001-37586 FILM NUMBER: 25757876 BUSINESS ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 BUSINESS PHONE: 8437402300 MAIL ADDRESS: STREET 1: 4920 O'HEAR AVENUE STREET 2: SUITE 400 CITY: NORTH CHARLESTON STATE: SC ZIP: 29405 DEFA14A 1 ef20045912_defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A   Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No.      ) Filed by the Registrant   ☒ Filed by a party other than the Registrant   ☐   Check the appropriate box:   ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy Statement ☒ Definitive Additional Materials ☐ Soliciting Material Pursuant to §240.14a-12 INGEVITY CORPORATION (Name of Registrant as Specified In Its Charter)   (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)   Payment of Filing Fee (Check the appropriate box):   ☒ No fee required. ☐ Fee paid previously with preliminary materials. ☐ Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11   On March 20, 2025, Ingevity Corporation issued the following press release and letter to its stockholders. Ingevity Files Definitive Proxy Statement and Issues Letter to Stockholders Board and Management Team Have Taken Significant and Decisive Action to Respond to External Market Challenges Key Transformational Changes Are Driving Strong Financial Results and Stock Price Outperformance Continued Execution of Proven Strategy Positions Ingevity to Unlock Significant Additional Stockholder Value Company Urges Stockholders to Vote “FOR” ONLY Ingevity’s Highly Qualified Director Nominees on the WHITE Proxy Card Launches VoteIngevity.com Providing Additional information for Stockholders NORTH CHARLESTON, S.C., Mar 20, 2025 – Ingevity Corporation (NYSE: NGVT) today announced that it has filed its definitive proxy statement with the U.S. Securities and Exchange Commission in connection with its 2025 Annual Meeting of Stockholders (the “Annual Meeting”), which will be held on April 30, 2025 at 9:30 a.m. (Eastern). All Ingevity stockholders of record as of the close of business on March 3, 2025 will be entitled to vote at the meeting. In conjunction with the filing of the definitive proxy, Ingevity’s Board of Directors issued a letter to stockholders recommending that they vote for Ingevity’s nine highly qualified and engaged directors on the WHITE proxy card - Jean S. Blackwell, Luis Fernandez-Moreno, Diane H. Gulyas, Bruce D. Hoechner, Frederick J. Lynch, Karen G. Narwold, Daniel F. Sansone, J. Kevin Willis and Benjamin G. (Shon) Wright. The Company also launched VoteIngevity.com, a website including voting instructions and other resources for stockholders. Highlights from the letter include: • Under the leadership of Ingevity’s Board and management team, the Company has undertaken a series of fundamental changes to the business in response to external market challenges. • Ingevity has seen the impact of these changes through its strong 2024 financi